Skip to content
To the full analysis

MiMedx Group stock: balance sheet and debt

MDXG
$3.24Closing price of 12 Nov 2026MEQIRI Score 37 out of 100

MiMedx Group has a debt to equity ratio of 0.09 and an interest coverage of 38.2x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.09
Interest coverage
38.2x
Current ratio
4.32
Cash & equivalents
$166.12M
Total assets
$342.65M
Equity ratio
74.9%
Goodwill
$19.44M
Plus intangible assets of $14.16M
Net debt
−$143.59M
More cash than debt

Total assets and equity ratio

How large the balance sheet of MiMedx Group, Inc. is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$13.85Knot reported separatelynot reported separately23.5%$3.65K
2007$184not reported separatelynot reported separately−19,346.7%$27.32K
2008$15.18M$6.64M$857.6K93.8%−$6.75M
2009$9.69M$5.45M$857.6K62.6%$337.32K
2010$7.35M$4.79M$857.6K83.0%−$937.49K
2011$27.1M$19.13M$4.04M43.9%−$71.76K
2012$35.18M$15.95M$4.04M56.9%−$2.74M
2013$84.69M$15.22M$4.04M86.9%−$44.08M
2014$109.26M$14.89M$4.04M81.8%−$52.33M
2015$135.91M$14.8M$4.04M79.5%−$31.35M
2016$193.26M$43.47M$20.2M68.8%−$34.36M
2017$121.26M$30.01M$19.98M60.9%−$27.19M
2018$122.84M$29.58M$19.98M40.4%−$44.89M
2019$167.17M$27.75M$19.98M20.6%$674K
2020$202.03M$25.98M$19.98M45.2%−$43.98M
2021$187.93M$25.36M$19.98M49.3%−$33.79M
2022$171.43M$25.29M$19.44M43.5%−$13.48M
2023$239.05M$24.7M$19.44M59.7%−$33.9M
2024$263.92M$31.07M$19.44M73.2%−$79.57M
2025$342.65M$33.6M$19.44M74.9%−$143.59M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$6.35K$3.26K$10K3.07
2007$184−$35.6K$27.5K−0.77
2008$6.75M$14.23M$00
2009$2.65M$6.07M$2.99M0.49
2010$1.34M$6.1M$403.43K0.07
2011$4.11M$11.9M$4.04M0.34
2012$6.75M$20.01M$4.01M0.2
2013$44.08M$73.57M$00
2014$52.33M$89.33M$00
2015$31.49M$107.99M$133K0
2016$34.39M$133M$31K0
2017$27.48M$73.8M$286K0
2018$45.12M$49.66M$229K0
2019$69.07M$34.4M$69.74M2.03
2020$95.81M$91.42M$51.83M0.57
2021$87.08M$92.58M$53.29M0.58
2022$65.95M$74.51M$52.47M0.7
2023$82M$142.72M$48.1M0.34
2024$104.42M$193.11M$24.84M0.13
2025$166.12M$256.55M$22.53M0.09

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 31 Jul 2026)
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy